Shin-Ichi Tsuda Kazunori Konishi Toshiki Otoda Takako Nagai Ai Takeda-Watanabe Megumi Kanasaki Munehiro Kitada Atsushi Nakagawa Makoto Nishizawa Keizo Kanasaki Daisuke Koya
10.2169/internalmedicine.55.7001
Intern Med
2016;55(23):3471-3473.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/27904111/
Diabetes Mellitus, Type 2 / drug therapy Dipeptidyl-Peptidase IV Inhibitors / therapeutic use Hypoglycemic Agents / therapeutic use Hypothalamo-Hypophyseal System / drug effects Pituitary-Adrenal System / drug effects Sitagliptin Phosphate / therapeutic use
Diabetes Mellitus, Type 2 / drug therapy Dipeptidyl-Peptidase IV Inhibitors / therapeutic use Hypoglycemic Agents / therapeutic use Hypothalamo-Hypophyseal System / drug effects Pituitary-Adrenal System / drug effects Sitagliptin Phosphate / therapeutic use Case Reports Aged Diabetes Mellitus, Type 2 / physiopathology Female Humans Hypoglycemia / physiopathology Hypothalamo-Hypophyseal System / physiopathology Pituitary-Adrenal System / physiopathology Dipeptidyl-Peptidase IV Inhibitors Hypoglycemic Agents Sitagliptin Phosphate
PMC5216145
27904111
Restoration of the Hypothalamic-pituitary-adrenal Response to Hypoglycemia in Type 2 Diabetes by Avoiding Chronic Hypoglycemia
2016